日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Integrative genomic analysis of DLBCL identifies immune environments associated with bispecific antibody response

对弥漫性大B细胞淋巴瘤(DLBCL)进行整合基因组分析,可识别与双特异性抗体反应相关的免疫环境。

Tumuluru, Sravya; Godfrey, James K; Cooper, Alan; Yu, Jovian; Chen, Xiufen; MacNabb, Brendan W; Venkataraman, Girish; Zha, Yuanyuan; Pelzer, Benedikt; Song, Joo; Duns, Gerben; Sworder, Brian J; Raj, Sandeep; Bolen, Christopher; Penuel, Elicia; Postovalova, Ekaterina; Kotlov, Nikita; Bagaev, Aleksander; Fowler, Nathan; Shouval, Roni; Smith, Sonali M; Alizadeh, Ash A; Steidl, Christian; Kline, Justin

AI-driven multimodal algorithm predicts immunotherapy and targeted therapy outcomes in clear cell renal cell carcinoma.

AI驱动的多模态算法预测透明细胞肾细胞癌的免疫疗法和靶向疗法疗效。

Stupichev Danil, Miheecheva Natalia, Postovalova Ekaterina, Lyu Yang, Ramachandran Akshaya, Galkin Ilya, Khegai Gleb, Perevoshchikova Kristina, Love Anna, Menshikova Sofia, Tarasov Artem, Svekolkin Viktor, Bruttan Maria, Varlamova Arina, Kriukov Kirill, Ataullakhanov Ravshan, Fowler Nathan, Cheng Emily, Bagaev Alexander, Hsieh James J

A phase 2 study of obinutuzumab combined with lenalidomide in previously untreated high tumor burden follicular lymphoma

一项针对既往未接受治疗的高肿瘤负荷滤泡性淋巴瘤患者的奥妥珠单抗联合来那度胺的 II 期研究

Akkad, Neha; Feng, Lei; Westin, Jason R; Hagemeister, Fredrick B; Lee, Hun Ju; Fayad, Luis; Ahmed, Sairah; Nair, Ranjit; Rodriguez, Maria Alma; Strati, Paolo; Chihara, Dai; Flowers, Christopher R; Claret, Linda; Ibanez, Karina; Wang, Michael; Fowler, Nathan H; Henderson, Jared; Davis, R Eric; Neelapu, Sattva S; Green, Michael; Nastoupil, Loretta J

MutAnt: mutation annotation tool predicts deleteriousness of missense mutations and improves mutation calling from transcriptomics

MutAnt:突变注释工具,可预测错义突变的有害性并改进转录组学中的突变检测。

Sarachakov, Aleksandr; Yudina, Anastasiya; Svekolkin, Viktor; Parfenenkova, Anna; Spektor, Miryam; Oshchepkova, Polina; Pak, Marina; Antysheva, Zoia; Balabanian, Linda; Brown, Jessica H; Feinberg, Max; Fowler, Nathan; Bagaev, Alexander

Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update

tisagenlecleucel治疗复发/难治性滤泡性淋巴瘤成人患者后获得持久疗效:ELARA试验最新进展

Dreyling, Martin; Fowler, Nathan Hale; Dickinson, Michael; Martinez-Lopez, Joaquin; Kolstad, Arne; Butler, Jason; Ghosh, Monalisa; Popplewell, Leslie; Chavez, Julio C; Bachy, Emmanuel; Kato, Koji; Harigae, Hideo; Kersten, Marie José; Andreadis, Charalambos; Riedell, Peter A; Ho, P Joy; Pérez-Simón, José Antonio; Chen, Andy I; Nastoupil, Loretta J; von Tresckow, Bastian; María Ferreri, Andrés José; Teshima, Takanori; Patten, Piers E M; McGuirk, Joseph P; Petzer, Andreas L; Offner, Fritz; Viardot, Andreas; Zinzani, Pier Luigi; Malladi, Ram; Paule, Ines; Zia, Aiesha; Awasthi, Rakesh; Han, Xia; Germano, Davide; O'Donovan, Darragh; Ramos, Roberto; Maier, Harald J; Masood, Aisha; Thieblemont, Catherine; Schuster, Stephen J

Safety and activity of lenalidomide in combination with obinutuzumab in patients with relapsed indolent non-Hodgkin lymphoma: a single group, open-label, phase 1/2 trial

来那度胺联合奥妥珠单抗治疗复发性惰性非霍奇金淋巴瘤患者的安全性和疗效:一项单组、开放标签、1/2期试验

Gurumurthi, Ashwath; Chin, Collin K; Feng, Lei; Fowler, Nathan H; Strati, Paolo; Hagemeister, Fredrick B; Fayad, Luis E; Westin, Jason R; Obi, Chizobam; Arafat, Janine; Nair, Ranjit; Steiner, Raphael E; Neelapu, Sattva S; Flowers, Christopher R; Nastoupil, Loretta J

Safety and efficacy of ibrutinib in combination with rituximab and lenalidomide in previously untreated follicular and marginal zone lymphoma: An open label, phase 2 study

伊布替尼联合利妥昔单抗和来那度胺治疗既往未接受治疗的滤泡性淋巴瘤和边缘区淋巴瘤的安全性和有效性:一项开放标签的 II 期研究

Gordon, Max J; Feng, Lei; Strati, Paolo; Lee, Hun Ju; Hagemeister, Fredrick B; Westin, Jason R; Samaniego, Felipe; Marques-Piubelli, Mario L; Vega Vazquez, Francisco; Parra Cuentas, Edwin R; Solis-Soto, Luisa M; Ma, Wencai; Wang, Jing; Claret, Linda; Averill, Barbara; Ibanez, Karina; Fayad, Luis E; Flowers, Christopher R; Green, Michael R; Davis, R Eric; Neelapu, Sattva S; Fowler, Nathan H; Nastoupil, Loretta J

Moving T-Cell Therapies into the Standard of Care for Patients with Relapsed or Refractory Follicular Lymphoma: A Review

将T细胞疗法纳入复发或难治性滤泡性淋巴瘤患者的标准治疗方案:综述

Fowler, Nathan Hale; Chavez, Julio C; Riedell, Peter A

Correction to: Moving T‑Cell Therapies into the Standard of Care for Patients with Relapsed or Refractory Follicular Lymphoma: A Review

更正:将T细胞疗法纳入复发或难治性滤泡性淋巴瘤患者的标准治疗:一项综述

Fowler, Nathan Hale; Chavez, Julio C; Riedell, Peter A

Integrative genomic analysis identifies unique immune environments associated with immunotherapy response in diffuse large B cell lymphoma

整合基因组分析揭示弥漫性大B细胞淋巴瘤免疫治疗反应相关的独特免疫环境

Tumuluru, Sravya; Godfrey, James K; Cooper, Alan; Yu, Jovian; Chen, Xiufen; MacNabb, Brendan W; Venkataraman, Girish; Zha, Yuanyuan; Pelzer, Benedikt; Song, Joo; Duns, Gerben; Sworder, Brian J; Bolen, Christopher; Penuel, Elicia; Postovalova, Ekaterina; Kotlov, Nikita; Bagaev, Aleksander; Fowler, Nathan; Smith, Sonali M; Alizadeh, Ash A; Steidl, Christian; Kline, Justin